IL159729A0 - Non-aqueous composition for oral delivery of insoluble bioactive agents - Google Patents

Non-aqueous composition for oral delivery of insoluble bioactive agents

Info

Publication number
IL159729A0
IL159729A0 IL15972904A IL15972904A IL159729A0 IL 159729 A0 IL159729 A0 IL 159729A0 IL 15972904 A IL15972904 A IL 15972904A IL 15972904 A IL15972904 A IL 15972904A IL 159729 A0 IL159729 A0 IL 159729A0
Authority
IL
Israel
Prior art keywords
aqueous composition
bioactive agents
oral delivery
insoluble bioactive
insoluble
Prior art date
Application number
IL15972904A
Other languages
English (en)
Original Assignee
Doron I Friedman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doron I Friedman filed Critical Doron I Friedman
Priority to IL15972904A priority Critical patent/IL159729A0/xx
Publication of IL159729A0 publication Critical patent/IL159729A0/xx
Priority to PCT/IL2004/001144 priority patent/WO2005065652A1/en
Priority to CA002547712A priority patent/CA2547712A1/en
Priority to US10/585,298 priority patent/US8187615B2/en
Priority to EP04806676A priority patent/EP1706100A4/en
Priority to JP2006548573A priority patent/JP2007517859A/ja
Priority to IL176502A priority patent/IL176502A0/en
Priority to MXPA06007783 priority patent/MXPA06007783A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15972904A 2004-01-06 2004-01-06 Non-aqueous composition for oral delivery of insoluble bioactive agents IL159729A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IL15972904A IL159729A0 (en) 2004-01-06 2004-01-06 Non-aqueous composition for oral delivery of insoluble bioactive agents
PCT/IL2004/001144 WO2005065652A1 (en) 2004-01-06 2004-12-19 Non-aqueous composition for oral delivery of insoluble bioactive agents
CA002547712A CA2547712A1 (en) 2004-01-06 2004-12-19 Non-aqueous composition for oral delivery of insoluble bioactive agents
US10/585,298 US8187615B2 (en) 2004-01-06 2004-12-19 Non-aqueous compositions for oral delivery of insoluble bioactive agents
EP04806676A EP1706100A4 (en) 2004-01-06 2004-12-19 NON-AQUEOUS COMPOSITION FOR THE ORAL ADMINISTRATION OF UNSUITABLE BIOACTIVE SUBSTANCES
JP2006548573A JP2007517859A (ja) 2004-01-06 2004-12-19 不溶性生物活性物質の経口投与用無水組成物
IL176502A IL176502A0 (en) 2004-01-06 2006-06-22 Non-aqueous composition for oral delivery of insoluble bioactive agents
MXPA06007783 MXPA06007783A (es) 2004-01-06 2006-07-06 Composicion no acuosa para el suministro oral de agentes bioactivos insolub

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15972904A IL159729A0 (en) 2004-01-06 2004-01-06 Non-aqueous composition for oral delivery of insoluble bioactive agents

Publications (1)

Publication Number Publication Date
IL159729A0 true IL159729A0 (en) 2004-06-20

Family

ID=33485391

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15972904A IL159729A0 (en) 2004-01-06 2004-01-06 Non-aqueous composition for oral delivery of insoluble bioactive agents
IL176502A IL176502A0 (en) 2004-01-06 2006-06-22 Non-aqueous composition for oral delivery of insoluble bioactive agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL176502A IL176502A0 (en) 2004-01-06 2006-06-22 Non-aqueous composition for oral delivery of insoluble bioactive agents

Country Status (7)

Country Link
US (1) US8187615B2 (xx)
EP (1) EP1706100A4 (xx)
JP (1) JP2007517859A (xx)
CA (1) CA2547712A1 (xx)
IL (2) IL159729A0 (xx)
MX (1) MXPA06007783A (xx)
WO (1) WO2005065652A1 (xx)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
NZ540166A (en) 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
MX2007011250A (es) 2005-03-21 2007-11-14 Ivax Pharmaceuticals Sro Inhibidor de la cristalizacion y su uso en capsulas de gelatina.
EP1818050A1 (de) * 2006-02-10 2007-08-15 Stada Arzneimittel Ag Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor
EP1825848A3 (de) * 2006-02-10 2010-03-03 Stada Arzneimittel Ag Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor
JP5459939B2 (ja) * 2006-06-09 2014-04-02 富士フイルム株式会社 カロチノイド含有エマルジョン組成物、その製造方法、それを含む食品及び化粧品
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
EP1886667A1 (en) * 2006-08-08 2008-02-13 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Microemulsified drug formulation
UA97653C2 (ru) * 2006-10-24 2012-03-12 Хелсинн Хелткер С.А. Мягкие капсулы, содержащие палоносетрона гидрохлорид, которые имеют улучшенную стабильность и биологическую доступность
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080311192A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Enteric-Coated Glucosinolates And Beta-Thioglucosidases
US20080311276A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Production of Glucosinolates from Agricultural By-Products & Waste
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
KR101545874B1 (ko) * 2007-09-03 2015-08-20 나노테라퓨틱스, 인코포레이티드 난용성 약물의 전달을 위한 입상 조성물
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2009119836A1 (ja) * 2008-03-28 2009-10-01 アンジェスＭｇ株式会社 転写因子デコイを有効成分とする外用剤組成物
US8697098B2 (en) 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
DE102008001811A1 (de) * 2008-05-15 2009-11-19 Beiersdorf Ag Kosmetische Zubereitungen zur Verminderung von Schweißgeruch mit ABCC-Modulatoren
WO2010041684A1 (ja) * 2008-10-08 2010-04-15 高田製薬株式会社 タクロリムス外用剤
JP2010132607A (ja) * 2008-12-05 2010-06-17 Taisho Pharm Ind Ltd アトピー性皮膚炎治療用軟膏剤
WO2010075065A2 (en) * 2008-12-15 2010-07-01 Banner Pharmacaps, Inc. Methods for enhancing the release and absorption of water insoluble active agents
JP2010202546A (ja) * 2009-03-02 2010-09-16 Taisho Pharm Ind Ltd アトピー性皮膚炎の治療用軟膏製剤
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
MY198422A (en) 2009-04-29 2023-08-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NZ627238A (en) 2009-04-29 2016-02-26 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
CA2762939C (en) 2009-05-22 2017-07-18 Mochida Phamaceutical Co., Ltd. Self-emulsifying composition of .omega.3 fatty acid
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US20100310726A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
MY172372A (en) 2009-06-15 2019-11-21 Amarin Pharmaceuticals Ie Ltd Compositions and methods for lowering triglycerides
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
RU2758369C2 (ru) 2009-09-23 2021-10-28 Амарин Фармасьютикалз Айрлэнд Лимитед Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина, и способы ее применения
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
TWI492744B (zh) * 2009-12-04 2015-07-21 Abbott Lab 使用類胡蘿蔔素調節早產兒發炎症之方法
ES2710149T3 (es) 2009-12-31 2019-04-23 Marius Pharmaceuticals Llc Modulación de la solubilidad, la estabilidad, la absorción, el metabolismo y el perfil farmacocinético de los fármacos lipófilos por esteroles
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
JP5676339B2 (ja) * 2011-03-29 2015-02-25 富士フイルム株式会社 脂肪低減剤
KR20130091761A (ko) * 2010-08-18 2013-08-19 클레어파르마 인더스트리즈 리미티드. 기능성 식품 조성물 및 그 제조방법
US20140080906A1 (en) * 2010-09-01 2014-03-20 Antioxidant Superfoods, Inc. Fat emulsion providing taste masking for active health and wellness ingredients
WO2012031119A1 (en) * 2010-09-01 2012-03-08 Antioxidant Superfoods, Inc. A fat emulsion providing improved health and taste characteristics in foods
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
US20140127289A1 (en) 2010-11-29 2014-05-08 Armarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
JP6009467B2 (ja) 2011-02-22 2016-10-19 コーディル・シード・カンパニー・インコーポレイテッドＣａｕｄｉｌｌ Ｓｅｅｄ Ｃｏｍｐａｎｙ， Ｉｎｃ． 噴霧乾燥ミロシナーゼ、及びイソチオシアネートを製造するための使用
EP2678001B1 (en) 2011-02-25 2017-04-05 South Dakota State University Polymer conjugated protein micelles
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
AU2013207368A1 (en) 2012-01-06 2014-07-24 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-CRP) in a subject
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
BR112014032905B1 (pt) 2012-06-29 2022-02-22 Amarin Pharmaceuticals Ireland Limited Uso de éster etílico do ácido eicosapentaenóico para redução do risco de morte cardiovascular, revascularização coronária e/ou angina instável em um indivíduo em terapia com estatina
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US10130576B2 (en) * 2012-11-13 2018-11-20 Johnson & Johnson Consumer Inc. Oral care compositions
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9072687B2 (en) 2013-02-26 2015-07-07 Mcneil-Ppc, Inc. Oral care compositions
US9125841B2 (en) 2013-02-26 2015-09-08 Johnson & Johnson Consumer Inc. Oral care compositions
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
WO2014143127A1 (en) 2013-03-15 2014-09-18 Differential Drug Development Associates Llc Emulsion formulations
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
WO2015022349A1 (en) * 2013-08-14 2015-02-19 Ratiopharm Gmbh Dosage form comprising enzalutamide
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CA2951284A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
TWI679029B (zh) * 2014-08-29 2019-12-11 日商富士化學工業股份有限公司 乳化組合物
US10166185B2 (en) 2015-06-09 2019-01-01 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
WO2016201119A1 (en) * 2015-06-09 2016-12-15 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
ES2607715B1 (es) * 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa
US9901576B2 (en) 2015-11-20 2018-02-27 West-Ward Pharmaceuticals International Limited Stable formulation of phenobarbital sodium injection
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
US9974722B2 (en) 2016-10-20 2018-05-22 Johnson & Johnson Consumer Inc. Reduced-ethanol mouth rinse formulations
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
CA2981267A1 (en) 2017-09-28 2019-03-28 Chuck Chang Curcuminoid chlorophyllin (chl) compositions and methods of preparation and use
CA2981394A1 (en) 2017-09-28 2019-03-28 Chuck Chang Curcuminoid compositions and preparation methods
EP3658110B1 (en) 2017-12-20 2023-04-05 Firmenich SA Oral care compositions
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
AU2019349563B2 (en) 2018-09-24 2023-06-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
GB201904767D0 (en) 2019-04-04 2019-05-22 Orexo Ab New pharmaceutical compositions
IT201900006573A1 (it) * 2019-05-06 2020-11-06 Gricar Chemical S R L Composizione liquida per la veicolazione di sostanze a bassa solubilità e bio-accessibilità enterica
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
HRP20221361T1 (hr) 2020-05-18 2023-01-06 Orexo Ab Novi farmaceutski sastav za davanje lijeka
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
NL2029172B1 (en) 2021-09-10 2023-03-21 Liposoma Health B V Lipid formulations for the preparation of health ingredient-containing hot drinks
KR20240103005A (ko) 2021-11-25 2024-07-03 오렉쏘 에이비 아드레날린을 포함하는 약학적 조성물
CN115969807B (zh) * 2023-01-17 2023-09-19 青岛双鲸药业股份有限公司 一种含生物活性成分的软胶囊内容物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
PE52896A1 (es) * 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
CN1098120C (zh) * 1996-05-23 2003-01-08 大正制药株式会社 微滴乳状液
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
IL138616A0 (en) * 2000-09-21 2001-10-31 J P M E D Ltd Oil in glycerin emulsion
IL129102A0 (en) 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
CN1431896A (zh) * 2000-04-04 2003-07-23 盐野义制药株式会社 含有高脂溶性药物的油性组合物
JP2002121929A (ja) 2000-10-13 2002-04-26 Takenaka Komuten Co Ltd エアークッションを備えた三次元浮体免震方法及び浮体免震構造物

Also Published As

Publication number Publication date
CA2547712A1 (en) 2005-07-21
US20070190080A1 (en) 2007-08-16
JP2007517859A (ja) 2007-07-05
WO2005065652A9 (en) 2006-08-03
MXPA06007783A (es) 2006-10-01
US8187615B2 (en) 2012-05-29
IL176502A0 (en) 2006-10-05
EP1706100A1 (en) 2006-10-04
WO2005065652A1 (en) 2005-07-21
EP1706100A4 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
IL176502A0 (en) Non-aqueous composition for oral delivery of insoluble bioactive agents
IL227117A (en) A pharmaceutical preparation that contains insulin in a form that allows oral administration
EP1615621A4 (en) COMPOSITIONS FOR ADMINISTERING DRUG COMBINATIONS
TWI366443B (en) Delivery of functional ingredients
SG113562A1 (en) Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
EP1807146A4 (en) COMPOSITION FOR IMPROVING THE EFFICACY OF DRUG DELIVERY
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
IL217713A0 (en) Compounds and compositions for delivering active agents
EP1806125A4 (en) LIQUID COMPOSITIONS FOR THE MOUTH CAVE
GB0408308D0 (en) Pharmaceutical compositions
EP1755633A4 (en) ORAL ADMINISTRATION OF PEPTIDE PHARMACEUTICAL COMPOSITIONS
EP1814591A4 (en) BIOACTIVE PREPARATIONS
IL177402A0 (en) Composition for oral administration of tamsulosin hydrochloride
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
EP1747004A4 (en) PHARMACEUTICAL COMPOSITIONS FOR METABOLIC INSUFFICIENCIES
EP1941896A4 (en) COMPOSITION CONTAINING A DIPEPTIDE FOR ORAL ADMINISTRATION
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
EP1858841A4 (en) STERILIZING COMPOSITION CONTAINING W-ALKOXYPEROXY CARBOXYLIC ACID
HK1098059A1 (en) Composition comprising itraconazole for oral administration
EP1797858A4 (en) PREPARATION FOR ORAL CAVITY
EP1747205A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0502792D0 (en) Pharmaceutical compositions